dc.contributor.author |
Vasilenko, Nicole |
|
dc.contributor.author |
Tieck, Maria P. |
|
dc.contributor.author |
Michel, Tanja |
|
dc.contributor.author |
Schembecker, Sonja |
|
dc.contributor.author |
Schwarz, Patricia |
|
dc.contributor.author |
Ruschil, Christoph |
|
dc.contributor.author |
Poli, Sven |
|
dc.contributor.author |
Ziemann, Ulf |
|
dc.contributor.author |
Giede-Jeppe, Antje |
|
dc.contributor.author |
Dulovic, Alex |
|
dc.contributor.author |
Günther, Anna |
|
dc.contributor.author |
Kowarik, Markus |
|
dc.date.accessioned |
2025-04-29T05:54:47Z |
|
dc.date.available |
2025-04-29T05:54:47Z |
|
dc.date.issued |
2024 |
|
dc.identifier.issn |
1664-3224 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/164764 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Lausanne : Frontiers Media Sa |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.3389/fimmu.2024.1487523 |
de_DE |
dc.subject.ddc |
570 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
In-depth analysis of serum antibodies against Epstein-Barr virus lifecycle proteins, and EBNA1, ANO2, GlialCAM and CRYAB peptides in patients with multiple sclerosis |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20250203000000_00112 |
|
utue.personen.roh |
Vasilenko, Nicole |
|
utue.personen.roh |
Tieck, Maria P. |
|
utue.personen.roh |
Michel, Tanja |
|
utue.personen.roh |
Schembecker, Sonja |
|
utue.personen.roh |
Schwarz, Patricia |
|
utue.personen.roh |
Guenther, Anna |
|
utue.personen.roh |
Ruschil, Christoph |
|
utue.personen.roh |
Poli, Sven |
|
utue.personen.roh |
Ziemann, Ulf |
|
utue.personen.roh |
Giede-Jeppe, Antje |
|
utue.personen.roh |
Gabernet, Gisela |
|
utue.personen.roh |
Dulovic, Alex |
|
utue.personen.roh |
Kowarik, Markus C. |
|
dcterms.isPartOf.ZSTitelID |
Frontiers in Immunology |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article 1487523 |
de_DE |
dcterms.isPartOf.ZS-Volume |
15 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |
utue.fakultaet |
07 Mathematisch-Naturwissenschaftliche Fakultät |
de_DE |